New peptide strategy may protect brain cells involved in Parkinson’s disease

Researchers on the Federal College of São Paulo (UNIFESP) in Brazil have found a brand new technique that will shield neurons and different mind cells concerned in Parkinson’s illness sooner or later. The outcomes of the research, which was carried out in mice, had been printed within the journal Neuropharmacology.

The research, which was supported by FAPESP, evaluated the impact of a peptide (Ac2-26) – a fraction of a protein (Annexin A1) – on the illness. This protein is produced naturally in each rodents and people, and former animal research have proven that the molecule controls neuroinflammation related to Parkinson’s illness and reduces neuronal degeneration.

Parkinson’s illness is carefully linked to neurons that synthesize and launch dopamine, an important neurotransmitter for motor features, motivation, reward, and pleasure. As these neurons degenerate and die because of the illness, the physique loses the power to synthesize dopamine. With out this substance, sufferers expertise impairments similar to freezing of gait (problem strolling) and tremors.

“It is nonetheless an experimental research in its very early levels, nevertheless it affords an attention-grabbing method by presenting a special technique from typical therapy. The peptide acts on neuroinflammation quite than on dopamine alternative. That is necessary as a result of, in neurodegenerative ailments, there’s an inflammatory response that impacts not solely neurons, but additionally surrounding cells, and the peptide mitigates that course of, consequently defending the mind from cell dying,” says Cristiane Damas Gil, head of the Division of Morphology and Genetics on the São Paulo Faculty of Drugs (EPM) at UNIFESP and writer of the research.

There may be at the moment no remedy for Parkinson’s illness. Therapy primarily focuses on controlling motor signs ensuing from dopamine deficiency. The therapeutic method is due to this fact primarily based on utilizing levodopa, a dopamine precursor that acts particularly on dopaminergic neurons.

“This treatment is taken into account the gold customary, providing vital advantages, particularly within the early levels or throughout acute therapy, when it results in a marked enchancment in motor signs. Nevertheless, long-term use diminishes its effectiveness and might result in the event of motor issues and fluctuations within the therapeutic response. That is why it is important to hunt therapy alternate options for such a posh illness as Parkinson’s,” explains Luiz Philipe de Souza Ferreira, a FAPESP scholarship recipient who carried out the analysis.

The Ac2-26 peptide is a widely known anti-inflammatory agent that has been examined for different ailments, although it has not but been developed into a medicine. Moreover, research point out that Annexin A1 is altered in Parkinson’s illness and is related to mind irritation and the dopaminergic neurons concerned in controlling motion.

Women and men

To simulate Parkinson’s illness, the researchers injected a neurotoxic drug into the animals’ brains, inducing neuronal dying and typical signs of the illness. Nearly concurrently with the intracerebral injection, the researchers administered the peptide intraperitoneally (into the stomach).

The research additionally confirmed variations in safety and illness development between female and male mice. Following the damage that simulated Parkinson’s illness, the researchers noticed that females carried out higher on motion assessments initially, however this distinction disappeared over time. “That larger resilience was current even within the absence of the Annexin A1 protein,” says Gil.

Experiments had been carried out on animals with the protein and on genetically modified animals with out it.

“In males, nonetheless, the lack of neurons was extra evident, which allowed us to obviously assess the results of therapy with the Ac2-26 peptide, which is able to defending in opposition to degeneration,” says Ferreira.

The experiments additionally revealed that inducing the illness profoundly alters the reproductive cycle of females, highlighting how Parkinson’s impacts the endocrine system. “This reinforces the necessity for particular protocols for every organic intercourse,” Ferreira emphasizes.

The present research confirmed that the peptide acts preventively, intervening on the onset of harm. “Our subsequent step is to analyze whether or not the peptide can reverse the injury attributable to Parkinson’s illness. If that is confirmed, then the peptide turns into a extra promising therapy candidate,” Gil concludes.